Knaster Alexander M's Form 4 filing
Privia Health Group, Inc. (PRVA) · filed Nov 23, 2022
- Accession no.
- 0001493152-22-033541
- Filed
- Nov 23, 2022, 4:05 PM ET
- Trade date
- Nov 21, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $51.4M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Knaster Alexander MCIK 0001308574 | 10% Owner |
| Pamplona Capital Management, LLCCIK 0001554913 | 10% Owner |
| Pamplona Capital Partners III, L.P.CIK 0001554914 | 10% Owner |
| Pamplona Capital Management, LLPCIK 0001554942 | 10% Owner |
| Pamplona PE Investments Malta LtdCIK 0001650903 | 10% Owner |
| Halsted John C.CIK 0001844403 | 10% Owner |
| Pamplona Equity Advisors III LtdCIK 0001859731 | 10% Owner |
| Pamplona PE Investments II, Ltd.CIK 0001915345 | 10% Owner |
| Pamplona Private Equity Carryco III, L.P.CIK 0001915347 | 10% Owner |
| Pamplona Equity Carryco Advisors III, Ltd.CIK 0001915350 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 | Common Stock | SSaleDisposed | −2,278,085 | $22.56F2 | −$51,393,597.6 | 17,741,723 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Pursuant to an underwriting agreement, dated November 16, 2022 (the "Underwriting Agreement"), and in connection with the public offering of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. (the "Company") by the Company, the Company sold 5,750,000 shares (including 750,000 additional shares which the underwriters had the right to purchase) of Common Stock pursuant to the final prospectus filed by the Company on November 16, 2022, which offering was consummated on November 21, 2022 (the "Public Offering"). The amount above represents the $23.50 public maximum offering price per share of Common Stock in the Public Offering less the underwriting discount of $0.94 per share of Common Stock. The shares sold were held by a private investor group, which includes PCP III and Carryco III.
Referenced by the price of 1 transaction in Table I.